Fred Driscoll

Mr. Frederick W.
Driscoll is a Non-Executive Chairman at Lite Strategy, Inc. and an Independent Director at Cellectar Biosciences, Inc. He is on the Board of Directors at NeoSoma, Inc., SmartPharm Therapeutics, Inc., Cellectar Biosciences, Inc. and Adipo Therapeutics LLC.
Mr. Driscoll was previously employed as an Independent Non-Executive Director by Calliditas Therapeutics AB, a Chief Financial Officer by Invivyd, Inc., a Secretary, Chief Financial & Accounting Officer by Renovacor, Inc., a Chief Financial Officer by Flexion Therapeutics, Inc., a Chief Financial Officer & Treasurer by ConforMIS, Inc., an Independent Director by Cue Biopharma, Inc., a Lead Independent Director by NantKwest, Inc., an Independent Director by Abpro Corp., a Chief Financial Officer by Flexion Therapeutics, Inc., a Chief Financial Officer, Treasurer & VP by Novavax, Inc., a President & Chief Executive Officer by Genelabs Technologies, Inc., a Chief Financial Officer by Astraris, Inc., a Chairman, President & Chief Executive Officer by Mateon Therapeutics, Inc., a Senior Vice President-Finance & Operations by Collagenesis Corp., and a Vice President-Finance-Americas & Controller by Instrumentation Laboratory Co. He also served on the board at Cynapsus Therapeutics, Inc. and ImmunityBio, Inc. He received his undergraduate degree from Bentley University.